Company intelligence / Profile preview

Lions Liquidity Investment Fund

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Lions Liquidity Investment Fund I is a Canadian venture capital fund managed by Lions Capital Corp. Based in Vancouver, British Columbia, the fund was established to provide early-stage financing and liquidity solutions to promising technology and life science companies. Its investment portfolio has included notable biopharmaceutical firms such as Sophiris Bio (formerly Protox Pharmaceuticals) and Aquinox Pharmaceuticals. The fund's management team also provides corporate advisory services, including mergers and acquisitions and financial restructuring for emerging growth companies.

Industry: Investors

Beyond the preview

Go deeper on Lions Liquidity Investment Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lions Liquidity Investment Fund.

Explore the full profile